Navigation Links
Yet Another Use For Green Tea Extract

Teavigo green tea extract has recently achieved GRAS (Generally Recognized As Safe) affirmation, giving food and beverage makers in the US a strong signal of the ingredient’s suitability in new food products. //

Although Teavigo is already being used in a number of supplement products in the Japanese and US market, under brands including GNC, Vitamin Shoppe and Healthy Origins, American food companies say they intend to wait for GRAS status before using a new ingredient in their products.

The GRAS dossier was supported by a 'package' of data on the safety of EGCG (epigallocatechin gallate), the major active component in green tea and a potent antioxidant, as well as animal trials and human tolerance studies using Teavigo itself.

South Africa, the only market that is already offering a wide range of food products containing the ingredient, products including an iced tea, sorbet, cereal bar and juice drink make the claim that Teavigo keeps body cells health and helps prevent damage caused by free radicals.

However researchers say results from several clinical trials investigating the product's effects on weight management, the application seeing most interest from both food and supplement makers, could have a bigger impact on the food market than safety, already accepted by supplement makers.

The first weight management food product containing Teavigo has just entered the Italian market in the form of a powder-based supplement for dieters, however researchers say there are many ongoing activities to develop more products in this field.

Medindia on Tea: Tea is a beverage made from the processed leaf of a plant whose Latin name is: Camellia sinensis. Some people who have been around for a long time in the tea industry still call it by its now out-dated name of Thea sinensis.

More on Medindia:

http://www.medindia.net/patients/
PatientInfo/superfoods_tea.htm
'"/>




Related medicine news :


1. Another ray of hope for Arthritis Sufferers
2. Another injectable contraceptive Pill approved by FDA
3. The Possibility Of Fighting HIV with Another Virus Questioned
4. New Research Has Found Another Use For Botox
5. Yet Another Harmful Consequence Of Smoking
6. Another Treatment Option for Benign Tumors
7. Yet Another Treatment Option For Cancer
8. Another Alternative For Diabetics On Insulin
9. Another Use For Epilepsy Drugs
10. Another Cause of Thyroid Cancer Discovered
11. Yet Another Use For Cell Phone Cameras
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/23/2017)... , ... February 23, 2017 , ... The 89th Academy ... winner of the 2016 National Education Policy Center Bunkum Award. We invite you to ... 2016. , This year’s Bunkum winner is the Center for American Progress (CAP), for ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... with a clinician-based audience, will be participating in Rare Disease Day events, hosted ... D.C. In addition, Rare Disease Report, a website, weekly e-newsletter and quarterly publication, ...
(Date:2/23/2017)... ... ... Los Angeles-based weight loss surgeon Michael Feiz, M.D., F.AC.S. will be appearing ... which will begin airing on February 24, 2017. The show chronicles the weight loss ... television series, “Here Comes Honey Boo Boo.” The earlier series from TLC lasted for ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... thought leadership , media relations, content marketing, social media management, corporate communications, SEO ... already in the state and in nearby New Hampshire, Massachusetts and Canada, Rosica ...
(Date:2/23/2017)... ... 23, 2017 , ... On April 13, 2017, The ... “Doping in Sport: How the Culture Might Change,” in conjunction with Pepperdine ... will be held at Pepperdine University in Malibu, California. , Sir Philip Craven, ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... , Feb. 23, 2017 ... insights on the various drugs being developed ... covers all the drugs that are in ... Clinical). The pipeline focuses on novel pharmacologic ... antibodies, stem cell therapies, recombinant proteins and ...
(Date:2/24/2017)... , Feb. 24, 2017  Xynomic Pharmaceuticals, Inc., ... announced that it has acquired exclusive worldwide rights ... best-in-class innovative HDAC inhibitor targeting hematological and solid ... 14 Phase 1 and 2 clinical trials of ... have already been completed, demonstrating that ...
(Date:2/23/2017)... Research and Markets has announced the addition of the ... report to their offering. ... The latest research Autism Spectrum Disorder Drugs Price ... in the global Autism Spectrum Disorder market. The research answers ... key drugs marketed for Autism Spectrum Disorder and their clinical attributes? ...
Breaking Medicine Technology: